Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemiaRizwan Romee, Todd A. Fehniger, Maximillian Rosario et al.|Science Translational Medicine|2016Cited by 916
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Allegra A. Petti et al.|New England Journal of Medicine|2016Cited by 783
Genomic landscape of neutrophilic leukemias of ambiguous diagnosisHaijiao Zhang, Jeffrey Tyner, Shannon K. McWeeney et al.|Blood|2019Cited by 84
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Robyn M. Scherber, Mariana Castells et al.|NEJM Evidence|2023Cited by 74
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosisRuben A. Mesa, Srđan Verstovšek, Claire Harrison et al.|Leukemia|2022Cited by 63